Patent · US Active

Glycogen synthase kinase-3 inhibitors

US8088941B2 · kind B2 · utility

0Cited by

18References

24Claims

0Family size

Assignee

TEL-AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L.P. · IL

Inventors

Hagit Eldar-Finkelman · Shoham, IL
Moshe Portnoy · Ramat HaSharon, IL

Key dates

Filing date	Apr 30, 2008
Grant date	Jan 3, 2012
Priority date	—
Expiry date	Apr 30, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2299/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.